4.7 Article

Regulation of hepatic coenzyme Q biosynthesis by dietary omega-3 polyunsaturated fatty acids

Journal

REDOX BIOLOGY
Volume 46, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.redox.2021.102061

Keywords

Coenzyme Q; PUFAs; MUFAs; Mevalonate pathway; Farnesyl diphosphate synthase; Zoledronic acid

Funding

  1. Ministerio de Ciencia, Innovacion y Universidades (MICIU) [RTI2018-100695-B-I00]
  2. Spanish Ministerio de Economia y Competitividad (MINECO) [BFU2015-64630-R, BFU2011-23578]
  3. Spanish Junta de Andalucia [P18-RT-4264, 1263735-R, BIO-276]
  4. FEDER Funding Program from the European Union
  5. Universidad de Cordoba
  6. Spanish Ministerio de Educacion, Cultura y Deporte [FPU12/03398, FPU13/04188]
  7. MINECO [BES-2016-078,229]
  8. National Science Foundation [MCB1330803]

Ask authors/readers for more resources

Research has found that n-3 series PUFAs have a regulatory effect on CoQ biosynthesis, increasing CoQ content, especially CoQ(10). This response was replicated in mouse liver and in hepatic cells cultured in vitro, with n-3 PUFAs regulating CoQ biosynthesis by upregulating several COQ proteins and farnesyl pyrophosphate levels.
Dietary fats are important for human health, yet it is not fully understood how different fats affect various health problems. Although polyunsaturated fatty acids (PUFAs) are generally considered as highly oxidizable, those of the n-3 series can ameliorate the risk of many age-related disorders. Coenzyme Q (CoQ) is both an essential component of the mitochondrial electron transport chain and the only lipid-soluble antioxidant that animal cells can synthesize. Previous work has documented the protective antioxidant properties of CoQ against the autoxidation products of PUFAs. Here, we have explored in vitro and in vivo models to better understand the regulation of CoQ biosynthesis by dietary fats. In mouse liver, PUFAs increased CoQ content, and PUFAs of the n-3 series increased preferentially CoQ(10). This response was recapitulated in hepatic cells cultured in the presence of lipid emulsions, where we additionally demonstrated a role for n-3 PUFAs as regulators of CoQ biosynthesis via the upregulation of several COQ proteins and farnesyl pyrophosphate levels. In both models, n-3 PUFAs altered the mitochondrial network without changing the overall mitochondrial mass. Furthermore, in cellular systems, n-3 PUFAs favored the synthesis of CoQ(10) over CoQ(9), thus altering the ratio between CoQ isoforms through a mechanism that involved downregulation of farnesyl diphosphate synthase activity. This effect was recapitulated by both siRNA silencing and by pharmacological inhibition of farnesyl diphosphate synthase with zoledronic acid. We highlight here the ability of n-3 PUFAs to regulate CoQ biosynthesis, CoQ content, and the ratio between its isoforms, which might be relevant to better understand the health benefits associated with this type of fat. Additionally, we identify for the first time zoledronic acid as a drug that inhibits CoQ biosynthesis, which must be also considered with respect to its biological effects on patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available